Evidence map›Paper›PMID 19432687›Full record

ReviewHemodialysis international. International Symposium on Home Hemodialysis2009

Hemodialysis vascular access monitoring: current concepts.

Michael Allon, Michelle L Robbin

Open access · greenAbstract readReview
In one paragraph

Review in Hemodialysis international. International Symposium on Home Hemodialysis, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Stenosis Characterization and Identification for Dialysis Vascular Access.... IEEE Signal Processing in Medicine and Biology Symposium (SPMB). IEEE Signal Processing in Medicine and Biology Symposium · 2018
    Article
  11. Arteriovenous Access Failure, Stenosis, and Thrombosis.Canadian journal of kidney health and disease · 2016
    Article
  12. Article
  13. Review
  14. Article
  15. Surveillance and monitoring of dialysis access.International journal of nephrology · 2012
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael AllonDivision of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. mdallon@uab.edu
Michelle L Robbin
University of Alabama at Birmingham · US

Funding

Vascular abnormalities in patients receiving a dialysis access.R01DK085027 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLON, MICHAEL · 2010 to 2013
$1.5M
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUMU01DK058968 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLON, MICHAEL · 2002 to 2007
$1.4M
NIDDK NIH HHS R01 DK085027NIDDK NIH HHS U01 DK058968
6 · The paper itself

Abstract

Most arteriovenous grafts fail due to irreversible thrombosis, and most clotted grafts have an underlying stenotic lesion. These observations raise the plausible hypothesis that early detection of graft stenosis with preemptive angioplasty will reduce the likelihood of graft thrombosis. A number of noninvasive methods can be used to detect hemodynamically significant graft stenosis with a high positive predictive value. These tests include clinical monitoring, as well as surveillance by static dialysis venous pressures, flow monitoring, or duplex ultrasound. However, these surveillance tests have a much lower positive predictive value for graft thrombosis in the absence of preemptive angioplasty. In other words, none of the currently available surveillance tests can reliably distinguish between stenosed grafts destined to clot, and those that will remain patent without intervention. As a consequence, any program of graft surveillance necessarily results in a substantial proportion of unnecessary angioplasties. Moreover, a substantial proportion of grafts thrombose despite a normal antecedent surveillance test. Numerous observational studies have found an impressive reduction of graft thrombosis after implementation of a stenosis surveillance program. In contrast, 5 of 6 randomized clinical trials failed to show a reduction of graft thrombosis in patients undergoing graft surveillance, as compared with those receiving only clinical monitoring. The lack of benefit of surveillance is largely attributable to the rapid recurrence of stenosis after angioplasty. Thus, routine surveillance for graft stenosis, with preemptive angioplasty, cannot be recommended for reduction of graft thrombosis. Future research should be directed at pharmacologic interventions to prevent graft stenosis.

Indexed as

Arteriovenous Shunt, SurgicalRenal DialysisAngioplastyGraft Occlusion, VascularHumansKidney Failure, ChronicRandomized Controlled Trials as Topic

Identifiers

PMID19432687
PMCPMC4017945
OpenAlexW2097829425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.